Comparison of the pathogenicity and neutrophil and monocyte response between SARS-CoV-2 prototype and Omicron BA.1 in a lethal mouse model.

Animal Model Exp Med · 2025 · PMC12008447 · PMID 38760905

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Compared with the Omicron BA.1 group, the proportion of lymphocytes in the SARS‐CoV‐2 prototype group exhibited a decreasing trend after 1 dpi, while no obvious changes were found in the Omicron BA.1 group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.